SciELO - Scientific Electronic Library Online

 
vol.26 número1Programa de vacunación en prisiones: impacto del virus SARS-CoV-2 y retos de futuroNecesidad de actualizar las recomendaciones para el control de la tuberculosis en las prisiones españolas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Española de Sanidad Penitenciaria

versión On-line ISSN 2013-6463versión impresa ISSN 1575-0620

Rev. esp. sanid. penit. vol.26 no.1 Barcelona ene./abr. 2024  Epub 16-Sep-2024

https://dx.doi.org/10.18176/resp.00084 

VISUAL IMAGE OF PRISON HEALTH CARE

Larval therapy in complicated vascular wounds

Larvaterapia en heridas vasculares complicadas

Agustín Mª Herrero-Matías1  , Bárbara Carmen Bodega-Martínez2  , Carlos Mínguez-Gallego3 

1Head of Medical Services. Centro Penitenciario Castellón I

2Angiology and Vascular Surgery Unit. Hospital General Universitario de Castellón

3Internal Medicine. Hospital La Magdalena. Castellón

CLINICAL CASE DESCRIPTION

On 10 October 2022, a 75-year-old man was referred to the vascular surgery unit of the reference hospital (Castellón General Hospital) for a months-long history of an ulcer on the back of the left foot (February 2022) that did not improve with topical treatment, with a history of smoking as a risk factor. There was chronic ischaemia of the left lower limb, with lesions on the left foot and leg. He had been previously examined at the outpatient unit of vascular surgery in May 2022 for femoropopliteal obliteration of the left lower limb with small uncomplicated periungual lesions.

The exploration of the lower limbs showed the following:

  • Right lower limb: pulse: femoral ++, popliteal + and pedis doubtful due to oedema.

  • Left lower limb: femoropopliteal obliteration. Ulcers on back of foot and pre-tibia with fibrin, granulation tissue and some necrotic areas, malodorous, exudative. Foot reddened and oedematous. Pain at rest. Knee with genu flexum deformity.

  • Ultrasound and venography of left lower limb: proximal internal saphenous vein of 5 mm diameter permeable from arch to halfway down the calf, up to where the examination could be carried out. Longitudinal R4 outlet that follows a line parallel to the internal saphenous vein, but more anterior, of about 3 mm diameter. Internal supragenicular saphenous vein of 4 mm, infragenicular of 3 mm, and internal saphenous vein at halfway point of calf of 2.5 mm. Ankle-brachial index of left lower limb on 13 October 2022: .31; and on 31 October 2022 (after bypass): 0.69.

  • Wound cultures on 31 November 2022: bacteriological culture of Escherichia coli.

  • Sensitive to piperacillin/tazobactam, fosfomycin and cefotaxime.

Principal diagnosis: Level IV critical ischaemia syndrome in left lower limb.

Secondary diagnoses: Leve IV chronic ischaemia in left lower limb and mixed ulcers in lower left limb.

EVOLUTION

A femoral distal bypass was carried out on 27 October 2022 with inverted saphenous vein under general anaesthesia, functional bypass, while a second intervention was carried out to debride the anterior tibial compartment. When the scab was raised, bone was exposed, revealing the tibial crest and uncomplicated dry necrosis of the heel and the exterior face of the left foot.

The ulcer was subsequently treated with surgical and chemical debridement, and attempted negative pressure therapy. Given the lack of improvement, larval therapy, also called biosurgery, was applied.

Use of this technique on this patient commenced at the hospital on 22 November 2022 (Figures 1 and 2), with the application of two bags of maggots. One of them was unconsciously extracted on the first night by the patient, who complained of “itching”. He extracted the second one on 25 November 2022. Given that the patient had been diagnosed with acute confusional syndrome and similar reactions were expected, treatment was interrupted.

Figure 1. Wound after bypass (23 November 2022). Application of larval therapy. 

Figure 2. Detail of bag of Lucilia sericata maggots (23 November 2022). 

Antibiotics were associated in line with the culture antibiogram (tazocel is the most widely used one), with good evolution until the ulcer, which occupied the entire anterior face of the leg to the base of the toes, was clean, with good highly superficial granulation tissue: favourable evolution with epithelisation of the edge and progressive granulation of exposed area of bone (Figure 3 [November 2022] and Figure 4 [June 2023]).

Figure 3. Immediate evolution (28 November 2022). 

Figure 4. Current condition (15 June 2023). 

FINAL COMMENTS

Larval therapy is a technique for curing ulcers that uses compression with bags containing maggots of the Lucilia sericata fly, the aim being that the maggots cause desquamation and cleaning of the necrotic areas. There are references to this therapy in the Bible1 and it is currently being studied and developed. It is postulated as an adequate therapy for treating major vascular wounds2-5.

In our case, although the patient himself, who was affected by confusional syndrome, was the causative factor that led to the treatment being interrupted (there are descriptions that it produces local dysesthesia and a sensation of heat), the attached images show that after a brief period of application of the maggots6, the result was very successful for the revascularisation and debridement of a large ulcer with bone exposure.

REFERENCES

1. Méndez Torre J. Beneficio de la terapia larval en heridas crónicas [Trabajo fin de grado]. [Internet]. La Coruña: Facultad de Enfermería y Podología. Universidad da Coruña; 2016. Disponible en: https://ruc.udc.es/dspace/bitstream/handle/2183/17795/MendezTorre_Jennifer_TFG_2016.pdf?sequence=2Links ]

2. Stadler F. The maggot therapy supply chain: a review of the literature and practice. Med Vet Entomol. 2020;34(1):1-9. doi: 10.1111/mve.12397. [ Links ]

3. Von Beckerath O, Kanya S, Gäbel G, Kröger K, Juntermanns B. Use of maggot debridement therapy in hospitalised patients in Germany. Int Wound J. 2020;17(1):10-15. doi: 10.1111/iwj.13204. [ Links ]

4. Rodríguez González P. Eficacia de la terapia larval en el tratamiento de heridas. Nure Inv. 2016;13(85):1-7. [ Links ]

5. Ventura Navarro C. Biocirugía: Desbridamiento mediante terapia larval. [Trabajo fin de grado]. [Internet]. La Palma: Facultad de Ciencias de la Salud: Sección Enfermería y Fisioterapia. Universidad de La Laguna; 2022. Disponible en: https://riull.ull.es/xmlui/bitstream/handle/915/28987/Biocirugia%20Desbridamiento%20Mediante%20Terapia%20Larval.pdf?sequence=1Links ]

6. Ballester Martínez L, Martínez Monleon E, Serra Perucho N, Palomar Llatas F. Utilización de la terapia larval en heridas desvitalizadas: Revisión bibliográfica. Enferm Dermatol. 2016;10(29):27-33. [ Links ]

Received: June 21, 2023; Accepted: June 22, 2023

Correspondence: Agustín Mª Herrero Matías. E-mail: tinin@comcas.es

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License